Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's a joke. "Today's activity" yes we had plenty, one
of the best days to trade yet seen. But what does that
have to do with my claim? NOTHING.
Provided they don't expire first--the shelf life of the
IP is part of the goat equation. It is *error* to ignore
time. If the firm continues to stumble along for another
ten years longs are screwed.
Those were programmed purchases, not exercises of discretion.
Do you suppose it coincidence that they happened to be the
same number of shares on the same day? It isn't--it reflects a factual matter,
the same number of shares were bought on the same day because
IT WAS SET UP TO HAPPEN AUTOMATICALLY. You are saying they
bought because they had an opinion. That is flat out pump
and you cannot get away with it here. V and I take truth
seriously, please take your trash where it belongs (Y!).
The depraved, who imagine they have moral force. They had
better lose or we are doomed. But what can you expect from
the NY SLIMES?
ATryn is safer than Thrombate, at least in theory
---------------------------------------------------
The putative advantage is problematic?
I think you are right in according power to emotion here.
If there were a vast supply of ATIII available from Talecris, it is hard to see why the FDA would grant orphan drug status.
------------------------------------
Makes sense.
This is a very important question.
The availability of Thrombate has always been a central issue.
I'm not calling him liar yet, maybe in the morning.
It's very dangerous to jump to conclusions, but when
truth knocks at your door...
It's academic for me, I got flat at .82, but I am certainly
watching very closely.
Material.
>you assume that I would know or
care about your math degree unless I was hiring you.<
Trust me, I would never take job in your shop!
>The very complicated asset
backed securities formula's were put together by mathematicians<
Really?
Trust me on this too: the plural of "formula"
is NOT "formula's"! If I put a finer point on it
the message would be deleted so I will have to let
it go at that.
>the folly of mathematicians<
Why do you hate us? DD has disclosed that his BS/Math was
taken from MIT. That place is no joke. I'm just a cow
college dude but IT HURTS MY GUTS to hear you diss our
asses. Are you really thinking that you are a superior
being by virtue of your lack of a mathematical credential?
That is beyond weird.
It blows my mind that anybody thinks the AH action is
worth noting. I'm just a presumably stupid "trader"
saying it is meaningless.
Dead on, class shown again.
If it's not too much to ask, could you couch that
by means of a grammatically correct sentence?
I see traffic at .8 and at .9 twelve minutes later.
Somebody is right and somebody is wrong.
I am very sorry I wasn't on the scene, it doesn't
get much hotter than that (except in Brazil).
no doubt
You are living proof that dedication to science and
good taste are compatible.
Nonetheless I accord a slight edge to Venezuela.
So, how is the DOW trade working out?
Perhaps of interest
http://www.freshpatents.com/-dt20090115ptan20090017557.php
"The present invention relates to novel antibodies against FVII, use for determining amount of correctly folded and intact FVII in a sample, as well as for purification and process optimization."
concur
On the other hand, rhymes with "gonzo".
> anyone selling before everything unfolds is foolish.<
Whatever. I remember Schazamm telling me about ten years
ago that I was a fool to buy at three and sell at four. Later we
saw forty dollars and, later yet, forty cents. Thanks for
sharing your assessment of my acumen.
>magic is not my thing<
Why not? Crowley defined magick as "that science which
aims at an understanding of oneself and the world of which
one is a part, and that art which aims at the application
of such understanding in the arena of action", tersely
recapitulated, "the craft of creating change in conformity
with will".
It is trivial to buy near the day low and sell near the
day high. Simply place limit sells at each cent above one's
last execution price and limit buys so below. On subsequent
execution, adjust the order stacks accordingly (which can be
done automatically if your broker offers internal conditional
order logic, eg Ameritrade Izone).
"Internal" meaning the conditioning of order issuance or
cancellation is predicated on your execution experience,
as opposed to external predicates such as "DJIA touches
8000".
>According to management GTC has enough cash now to go thru the 1H09.<
No. You are leaving out the repayment of the note, which
is due in 1H09. Going through 1H09 means paying all the
bills, not just some of them.
Weren't all of those things true before you sold?
>i would like to thank one special poster here, io_io<
As he has been banned from this board by IHub management
you might want go drool on his tool over at IV, where he
can reciprocate.
>Actually, that LEO deal was announced about 3 1/2 years not 5 years.<
Actually you are wasting your time with your feeble attempts
to inject truth into these proceedings--it is not now and
never will be germane here.
OT for the most part, a stupendous read
http://www.scribd.com/doc/2547938/History-of-Medicine-Days
>they have paid an increased dividend since 1912...
Nice marketing bullet but I wouldn't call it dilly
until you convert the payouts to present dollars.
> I wouldn't be too excited about the volume being caused by a new partner or any knowledge about the Atryn decision.<
According to the TA tribe high volume when not accompanied
by significant price movement signals either accumulation
or distribution. If the price is high (when measured against
the past) it is distribution; if low, accumulation. To say
we are seeing accumulation at the present price is to take as
the standard of reference hope rather than history.
To continue being argumentative, and in the spirit of
vapidity that is this board's numen, extended hours
trading doesn't ever matter to spectators. For
the rest of us it's our just desert, and sometimes--like
the INSM I got off at .55 a little while ago--dessert.
Those who paid .74 in the premarket lost money. Duh, I
wonder how those who traded with them did? Don't they
know they are supposed to be accumulating shares rather
than money?
> If Teva were planning to work with GTC, they would absolutely not need to ink a big new collaboration with Lonza<
You conflate absence of necessity with absence of incentive,
and imo improperly view the scope of the joint venture as
evidently limited to non-transgenic production. I don't see
the advent of the joint venture as conditioning the probabilities
of prospective licensing arrangements with
either of them, apart from the flow therefrom to the new
alternative of dealing with the JV itself. If they are
small there is scant warrant to reckon their change anyway.
Whether his arrow meets its mark or not I am curious
as to what strung the bow.
>Hugh overhang from LFB deal at 0.31 cents<
Premising that LFB's shares, present or prospective,
should be viewed as supply (part of the float) is just
the sort of thing we have come to expect from you.
Six months on the brink, could that signify
brinksmanship?
>sickening to have watched it happen<
Albeit unsurprising.
>After all, originally GTCB was a GENZ baby and they still own a stake in the company<
I don't see those factors as germane but I do put GENZ on the short list of potential suitors.
>I know there are cheaper
Yes you do, since I have told you several times that in a Zecco account with at least $2500 equity the first ten trades
each month are free.